Interleukin-1 beta (IL-1β) plays a crucial role in the acute phase of stroke within the inflammatory cascade and serves as a long-term chronic contributor to atherosclerosis development and increased stroke risk. This evidence concerns the gene IL1B and atherosclerosis.